Exencial Wealth Advisors, LLC Gilead Sciences, Inc. Transaction History

Exencial Wealth Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$71.58 - $87.29 $161,913 - $197,449	-2,262 Reduced 42.78%	3,026 $221,000
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $179,218 - $203,238	2,446 Added 86.07%	5,288 $428,000
Q3 2023 Nov 08, 2023	SELL	$73.94 - $80.67 $16,118 - $17,586	-218 Reduced 7.12%	2,842 $212,000
Q2 2023 Aug 10, 2023	BUY	$76.01 - $86.7 $6,916 - $7,889	91 Added 3.07%	3,060 $235,000
Q1 2023 May 02, 2023	BUY	$77.31 - $88.08 $19,714 - $22,460	255 Added 9.4%	2,969 $246,000
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $169,136 - $242,821	2,714 New	2,714 $232,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.